?

CurrentPartnering

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Research Reports By CurrentPartnering

Found 391 publications
HIV Partnering 2010-2015 US$ 1,795.00 May, 2015 150 pages
Tropical Disease Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Sleep Disorders Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Glaucoma Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Depression Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
MRSA Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Anemia Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Fungal Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Cystic Fibrosis Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Allergy Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Alzheimer's Disease Partnering 2010-2015 US$ 1,795.00 May, 2015 100 pages
Infertility Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Herpes simplex Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Sepsis Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Schizophrenia Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Dementia Partnering 2010-2015 US$ 1,795.00 May, 2015 100 pages
Hearing Disorders Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Malaria Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Human Papilloma Virus Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
AIDS Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Transplantation Partnering 2010-2015 US$ 995.00 May, 2015 100 pages
Hepatitis Partnering 2010-2015 US$ 995.00 May, 2015 150 pages
Dry Eye Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Sexual Dysfunction Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Ebola Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Influenza Partnering 2010-2015 US$ 995.00 May, 2015 100 pages
Tuberculosis Partnering 2010-2015 US$ 995.00 May, 2015 100 pages
Inflammatory Partnering 2010-2015 US$ 995.00 May, 2015 200 pages
COPD Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Systemic Lupus Erythematosus Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Parasitic Disease Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Bacterial Partnering Terms and Agreements US$ 1,795.00 May, 2015 801 pages
Hemophilia Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Drug Addiction Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Clostridium Difficile Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Obesity Partnering 2010-2015 US$ 995.00 May, 2015 100 pages
Viral Partnering Terms and Agreements US$ 1,795.00 May, 2015 456 pages
Dengue Fever Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Asthma Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Surgery Partnering 2010-2015 US$ 1,795.00 May, 2015 200 pages
Accident & Emergency Partnering 2010-2015 US$ 995.00 May, 2015 100 pages
Anthrax Partnering 2010-2015 US$ 795.00 May, 2015 150 pages
Retinopathy Partnering 2010-2015 US$ 795.00 May, 2015 100 pages
Top 50 Big Pharma Partnering and M&A Deal Trends US$ 3,495.00 Apr, 2015 798 pages
1 2 3 4 5 ... 8
Skip to top

News & Press-Releases by CurrentPartnering